PACB logo

PACB
Pacific Biosciences of California Inc

14,331
Mkt Cap
$425.82M
Volume
2,379.00
52W High
$2.73
52W Low
$0.8511
PE Ratio
-3.17
PACB Fundamentals
Price
$1.36
Prev Close
$1.41
Open
$1.42
50D MA
$1.47
Beta
2.06
Avg. Volume
6.16M
EPS (Annual)
-$1.82
P/B
177.82
Rev/Employee
$329,907.22
$983.82
Loading...
Loading...
News
all
press releases
PACB Q1 Earnings Beat, Revenues Miss Estimates, Gross Margin Down
PacBio beats Q1 earnings estimates as consumables growth and cost cuts offset flat revenue and a weaker gross margin.
Zacks·4d ago
News Placeholder
More News
News Placeholder
Pacific Biosciences of California (PACB) Reports Q1 Loss, Lags Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of +29.41% and -9.32%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4d ago
News Placeholder
PacBio Pre-Q1 Analysis: Time to Buy, Hold or Sell the Stock Now?
PACB heads into Q1 earnings with strong consumables momentum, but muted academic demand and macro pressures cloud near-term visibility.
Zacks·7d ago
News Placeholder
OrthoPediatrics (KIDS) Reports Q1 Loss, Beats Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -10.53% and +2.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·11d ago
News Placeholder
Pacific Biosciences of California (PACB) Projected to Post Quarterly Earnings on Thursday
Pacific Biosciences of California (NASDAQ:PACB) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...
MarketBeat·12d ago
News Placeholder
Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know
In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.47, denoting a -6.96% move from the preceding trading day.
Zacks·12d ago
News Placeholder
Pacific Biosciences of California (PACB) Stock Declines While Market Improves: Some Information for Investors
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.71, marking a -1.16% move from the previous day.
Zacks·19d ago
News Placeholder
PacBio & Lucid Genomics Partner to Boost Data Analysis, Stock Up
PACB stock gains on Lucid Genomics deal, boosting HiFi data analysis and simplifying workflows to speed insights and expand adoption.
Zacks·20d ago
News Placeholder
CareDx Launches AlloSeq Nano for High-Resolution Rapid HLA Typing
CDNA unveils AlloSeq Nano, delivering high-resolution HLA typing in under 3 hours, aiming to boost transplant diagnostics speed and lab efficiency.
Zacks·21d ago
News Placeholder
Here's Why You Should Add Solventum Stock to Your Portfolio Now
SOLV rides on strong segment demand, innovation push and cost savings plan, but tariffs and rising input costs cloud margin outlook.
Zacks·21d ago
<
1
2
...
>

Latest PACB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.